Related Experiment Video
Updated: Oct 30, 2025
07:05
Ultrasound-guided Botulinum Toxin-A Injections: A Method of Treating Sialorrhea
Published on: November 9, 2016
23.7K
Current treatment options for craniofacial hyperhidrosis
Nelson Wolosker1,2, Carolina Brito Faustino1, Marcelo Fiorelli Alexandrino da Silva1
1Hospital Israelita Albert Einstein, São Paulo, SP, Brasil.
Jornal Vascular Brasileiro
|July 2, 2021
Summary
Craniofacial hyperhidrosis (FH) affects nearly 10% of hyperhidrosis patients. Clinical treatment with oxybutynin hydrochloride shows over 70% efficacy, offering a safe first-line option before considering surgery.
Area of Science:
- Dermatology
- Neurology
Background:
- Hyperhidrosis (HH) involves excessive sweating beyond physiological needs.
- Craniofacial hyperhidrosis (FH) accounts for approximately 9.41% of all HH cases.
Purpose of the Study:
- To review current literature on craniofacial hyperhidrosis.
- To cover pathophysiology, diagnosis, clinical presentation, and treatment outcomes.
Main Methods:
- Literature review of recent data on craniofacial hyperhidrosis.
- Analysis of clinical and surgical treatment options and their outcomes.
Main Results:
- Both clinical and surgical treatments for FH show positive results.
- Oxybutynin hydrochloride offers clinical improvement in over 70% of patients.
- Surgical treatment for FH is linked to a higher complication rate.
Conclusions:
- Clinical treatment with oxybutynin hydrochloride is a viable first-line therapeutic option for FH.
- Surgical intervention for FH can be considered when clinical treatments are unsatisfactory and patient conditions permit.
Related Concept Videos
01:22Methods of reducing fever
924
The signs and symptoms of fever include hot and dry skin, flushed face, thirst, muscle aches, anorexia, headache, tachycardia, tachypnea, and fatigue. Elevated body temperature is reduced using two methods: pharmacological and nonpharmacological. Proper identification and treatment of the root cause of a fever is of utmost importance.
Pharmacological Methods of Reducing Fever:
Pharmacological Methods of Reducing Fever:
924
01:20Accessory Structures of the Skin: Sweat Glands
3.1K
Sweat glands or sudoriferous glands are one of the important accessory structures of the skin. They are small, coiled tubular structures located in the dermis, the middle layer of the skin. Sweat glands are responsible for producing and secreting sweat, a watery fluid that helps regulate body temperature and excrete waste products.
Sweat glands are classified as merocrine glands; that is, the secretions are excreted by exocytosis through a duct without affecting the cells of the gland. There...
Sweat glands are classified as merocrine glands; that is, the secretions are excreted by exocytosis through a duct without affecting the cells of the gland. There...
3.1K
01:27Open Angle Glaucoma: Treatment
772
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
772
01:23Hand hygiene
4.9K
Asepsis is the practice of preventing or breaking the chain of infection. The nurse employs aseptic techniques to prevent the spread of microorganisms and reduce the risk of diseases. Hand hygiene is the cornerstone of aseptic techniques and is classified into medical and surgical asepsis. Medical asepsis includes hand hygiene and the use of gloves. Surgical asepsis, or the sterile technique, refers to practices that render and keep objects and areas free of microorganisms.
Hand washing...
Hand washing...
4.9K
01:24Cystic Fibrosis: Management
283
Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
Sinus disease and chronic...
283
01:11Direct-Acting Cholinergic Agonists: Therapeutic Uses
1.2K
Direct-acting cholinergic agonists have many therapeutic uses in various medical fields. Choline esters, including acetylcholine, have limited clinical utility due to their non-selectivity and short duration of action. Still, acetylcholine and carbachol are applied topically during ophthalmologic surgery to induce miosis. Pilocarpine, a muscarinic and ganglionic stimulator, effectively treats open-angle glaucoma and alleviates xerostomia and dry mouth caused by radiotherapy or Sjögren...
1.2K